Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Statistics

Total Valuation

ATNM has a market cap or net worth of $55.45 million. The enterprise value is -$28.73 million.

Market Cap	55.45M
Enterprise Value	-28.73M

Important Dates

The next estimated earnings date is Thursday, October 31, 2024, after market close.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

ATNM has 31.15 million shares outstanding. The number of shares has increased by 9.64% in one year.

Shares Outstanding	31.15M
Shares Change (YoY)	+9.64%
Shares Change (QoQ)	+7.95%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	27.35%
Float	30.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.24
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.95, with a Debt / Equity ratio of 0.04.

Current Ratio	8.95
Quick Ratio	8.84
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -87.96% and return on invested capital (ROIC) is -57.75%.

Return on Equity (ROE)	-87.96%
Return on Assets (ROA)	-30.91%
Return on Capital (ROIC)	-57.75%
Revenue Per Employee	$1,653
Profits Per Employee	-$869,857
Employee Count	49
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.74% in the last 52 weeks. The beta is 0.15, so ATNM's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-72.74%
50-Day Moving Average	4.76
200-Day Moving Average	6.35
Relative Strength Index (RSI)	26.13
Average Volume (20 Days)	600,066

Short Selling Information

The latest short interest is 2.13 million, so 6.85% of the outstanding shares have been sold short.

Short Interest	2.13M
Short Previous Month	2.15M
Short % of Shares Out	6.85%
Short % of Float	7.03%
Short Ratio (days to cover)	1.38

Income Statement

In the last 12 months, ATNM had revenue of $81,000 and -$42.62 million in losses. Loss per share was -$1.52.

Revenue	81,000
Gross Profit	81,000
Operating Income	-46.71M
Pretax Income	-42.62M
Net Income	-42.62M
EBITDA	-46.49M
EBIT	-46.71M
Loss Per Share	-$1.52

Balance Sheet

The company has $86.04 million in cash and $1.85 million in debt, giving a net cash position of $84.19 million or $2.70 per share.

Cash & Cash Equivalents	86.04M
Total Debt	1.85M
Net Cash	84.19M
Net Cash Per Share	$2.70
Equity (Book Value)	43.84M
Book Value Per Share	1.43
Working Capital	77.34M

Cash Flow

In the last 12 months, operating cash flow was -$33.96 million and capital expenditures -$41,000, giving a free cash flow of -$34.00 million.

Operating Cash Flow	-33.96M
Capital Expenditures	-41,000
Free Cash Flow	-34.00M
FCF Per Share	-$1.09

Margins

Gross Margin	100.00%
Operating Margin	-57,665.43%
Pretax Margin	-52,620.99%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-41,977.78%

Dividends & Yields

ATNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.64%
Shareholder Yield	-9.64%
Earnings Yield	-76.86%
FCF Yield	-61.31%

Analyst Forecast

The average price target for ATNM is $13.77, which is 673.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.77
Price Target Difference	673.60%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	441.44%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 11, 2020. It was a reverse split with a ratio of 0.03333333:1.

Last Split Date	Aug 11, 2020
Split Type	Reverse
Split Ratio	0.03333333:1

Scores

ATNM has an Altman Z-Score of -3.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.84
Piotroski F-Score	2